Higher fasting C-peptide and fasting insulin, emerging from our rotating factor analysis, were found in NAFLD patients, as reported by Han and colleagues [31], and insulin-resistant patients commonly exhibited increased insulin serum levels. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.